New Study Shows Bacteria in Mouth and Intestines Can Help Reduce Peanut Allergies
A recent study has discovered that certain bacteria living in our mouths and intestines have the ability to deactivate the proteins that trigger allergic reactions to peanuts. This finding could potentially lead to new ways to help individuals with severe peanut allergies better manage their condition. However, it is important to note that further research and development are still needed before this approach can be widely implemented.
The research team, comprising scientists from the Autonomous University of Madrid in Spain and McMaster University in Canada, identified two specific microbes – Rothia and Staphylococcus – that possess this unique capability. These bacteria, naturally present in human saliva and the small intestine, can break down the proteins in peanuts that typically result in life-threatening anaphylactic reactions.
Anaphylaxis, a severe allergic response, is a significant concern for individuals with peanut allergies, particularly children. While peanut allergies affect up to 2 percent of people in Europe and the US, the rates are even higher among children, who face a greater risk of experiencing fatal reactions.
The immune system’s response to peanut proteins, specifically Ara h 1 and 2, can trigger an exaggerated inflammatory reaction in individuals with severe peanut allergies. This overreaction, known as anaphylactic shock, can lead to throat swelling and a drop in blood pressure, posing a serious threat to health.
In a clinical study involving 19 children with peanut allergies, researchers found that individuals with a higher abundance of bacteria capable of breaking down peanut proteins exhibited greater tolerance to the allergen and experienced milder allergic responses. Conversely, those with lower levels of these beneficial bacteria had a lower threshold for peanut exposure and experienced more severe reactions.
The study also involved experiments on mice, which demonstrated how Rothia and Staphylococcus can effectively break down Ara h 1 and 2, potentially reducing the triggers that activate the immune system. By introducing these bacteria into mice prone to peanut anaphylaxis, researchers were able to significantly reduce the severity of their allergic reactions.
While these findings hold promise for the future management of peanut allergies, further research is needed to explore potential treatment options, such as probiotics, which could help individuals with severe allergies. The researchers emphasize the importance of understanding the role of the human microbiota in modulating allergic reactions and highlight the therapeutic potential of utilizing bacteria to manage food allergies.
The study, published in Cell Host & Microbe, underscores the significance of leveraging microbial capabilities to address food allergies and potentially improve the quality of life for individuals with severe allergic conditions. It is essential to continue investigating these findings to develop safe and effective strategies for allergy management.
By leveraging the insights from this study, researchers aim to pave the way for innovative approaches to managing peanut allergies and enhancing the well-being of individuals affected by these conditions.
